Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kengne SW et al. – Mild to moderate CsAN occurs in approximately one third of patients who have SDNS and are treated with CsA for >3 yr. The data suggest that patients who require high dosages of CsA or treatment for hypertension, in particular when ACEIs/ARBs are used, are at higher risk for CsAN.


Today in Chronic Dz/Renal Failure...keeping you current

Nephrogenic systemic fibrosis
Current Opinion in Rheumatology, 11/04/09

Vitamin D compounds for people with chronic kidney disease not requiring dialysis
Cochrane Reviews, 10/23/09

Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery
Critical Care, 11/06/09

Today in Glomerular/Tubular Dz...keeping you current

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09

Change in Estimated GFR Associates with Coronary Heart Disease and Mortality
Journal of the American Society of Nephrology, 11/23/09

Biomarkers for Lupus Nephritis: The Quest Continues
Clinical Journal of the American Society of Nephrology, 11/13/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address